STSS Sharps Technology Inc

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)

o Rule 13d-1(c)

o Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

CUSIP No.  82003F101

SCHEDULE 13G

Page 2 of 6 Pages

 

1	NAME OF REPORTING PERSONS   Walleye Capital LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION   Minnesota
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER   1,000,026
		6	SHARED VOTING POWER   0
		7	SOLE DISPOSITIVE POWER   1,000,026
		8	SHARED DISPOSITIVE POWER   0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   1,000,026
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES			o
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)   6.55%
12	TYPE OF REPORTING PERSON   IA

 

---

---

 

 

CUSIP No.  82003F101

SCHEDULE 13G

Page 3 of 6 Pages

 

Item 1.

(a) Name of Issuer

Sharps Technology, Inc.

Item 1.

(b) Address of Issuer’s Principal Executive Offices

105 Maxess Road

Melville, New York 11747

Item 2.

(a, b, c) Names of Person Filing, Address of Principal Business Office, Citizenship:

Walleye Capital LLC, a Minnesota limited liability company

315 Park Ave. South

New York, NY 10010

  

Item 2.

(d) Title of Class of Securities

Common Stock, $0.0001 par value

 

Item 2.

(e) CUSIP No.:

82003F101

 

CUSIP No.  82003F101

SCHEDULE 13G

Page 4 of 6 Pages

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

	(a)	o	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
	(b)	¨	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
	(c)	¨	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
	(d)	¨	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
	(e)	x	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
	(f)	¨	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
	(g)	¨	A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
	(h)	¨	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
	(i)	¨	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
	(j)	¨	A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
	(k)	¨	A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:

 

CUSIP No.  82003F101

SCHEDULE 13G

Page 5 of 6 Pages

 

 

Item 4. Ownership

Information with respect to the Reporting Person’s ownership of the Common Stock, $0.0001 par value as of December 31, 2023, is incorporated by reference to items (5) - (9) and (11) of the cover page for the Reporting Person.

The amount beneficially owned by the Reporting Person is determined based on 15,274,457 shares of Common Stock, $0.0001 par value, outstanding as of November 14, 2023.

---

Sharps Technology (NASDAQ:STSS)
過去 株価チャート
から 4 2024 まで 5 2024

Sharps Technology (NASDAQ:STSS)
過去 株価チャート
から 5 2023 まで 5 2024

ニュース - Sharps Technology Inc

Form 8-K - Current report 土曜日 9年3月2024日 (2月前) • Edgar (US Regulatory)

Form 8-K - Current report 金曜日 8年3月2024日 (2月前) • Edgar (US Regulatory)

Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems 木曜日 7年3月2024日 (2月前) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities 木曜日 22年2月2024日 (3月前) • Edgar (US Regulatory)

Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia 水曜日 21年2月2024日 (3月前) • GlobeNewswire Inc.

Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems 土曜日 17年2月2024日 (3月前) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals 木曜日 15年2月2024日 (3月前) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities 木曜日 8年2月2024日 (3月前) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities 火曜日 6年2月2024日 (3月前) • Edgar (US Regulatory)

Form 8-K - Current report 土曜日 20年1月2024日 (4月前) • Edgar (US Regulatory)

Form 8-K - Current report 木曜日 18年1月2024日 (4月前) • Edgar (US Regulatory)

Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems 木曜日 18年1月2024日 (4月前) • GlobeNewswire Inc.

その他のSharps Technology Incニュース記事

Sharps Technology (NASDAQ:STSS)
日足 株価チャート
金曜日 10年5月2024日